Back to search

National and Kapodistrian University of Athens

Μελέτη του μεταβολισμού των οστών σε παιδιά με σακχαρώδη διαβήτη τύπου Ι: ο ρόλος της σκληροστίνης

Abstract

dc:description

Introduction: Diabetes Mellitus (DM) is a risk factor for reduced bone mass. Several bone metabolic pathways seem to be disrupted in patients with type 1 diabetes mellitus (T1DM), leading to the observed reduced Bone Mineral Density (BMD). Sclerostin and dickkopf-1 are inhibitors of the Wnt/b-catenin bone metabolic pathway. Increased sclerostin and dickkopf-1 levels and have been documented in adult patients with Diabetes Mellitus (DM), predominantly in those with T2DM. No relevant data exist on childhood T1DM. Furthermore, Osteoprotegerin (OPG) has been found higher in young T1DM patients, while Receptor Activator of Nuclear factor-KappaB Ligand(s-RANKL) has been found with comparable levels to controls.Aims Our aim was to study plasma sclerostin, dickkopf-1, OPG and s-RANKL concentration in children and adolescents with T1DM and controls and to correlate their levels with metabolic bone markers and BMD.Materials and Methods: We evaluated 40 children and adolescents with T1DM (mean±SD age 13.04±3.53 years, mean±SD T1DM duration 5.15±3.33years) and 40 healthy age- and gender-matched controls (mean±SD age 12.99±3.3years). Sclerostin, dickkopf-1, OPG, s-RANKL, Osteocalcin, C-telopeptide crosslinks-CTX, electrolytes, PTH, total alkaline phosphatise (ALP) and 25(OH)D were measured. Lumbar spine and total body Bone Mineral Density(BMD) were evaluated with dual energy X-ray absorptiometry (DXA). Results: Patients had significantly lower BMD than controls (L1-L4 BMD Z-score -0.17SD vs 0.23SD, p=0.03, total body BMD Z-score 0.23SD vs 0.56SD, p=0.04). Patients had significantly higher levels of OPG (6.15±1.56 vs 5.01±1.5 pmol/L, p<0.001), s-RANKL(logS-RANKL 5.97±0.63 vs 5.51±0.84, p=0.004) and ALP and lower levels of PTH and magnesium. Patients and controls had comparable 25(OH)vitD levels, while one third of both groups had low 25(OH)vitD levels(<20ng/ml). Osteocalcin was highly correlated with CTX in both groups (r=0.75, p<0.001), indicating coupling of bone resorption and formation but lower levels of both markers in patients could indicate lower bone turnover and osteoblastic disorder. OPG and s-RANKL were associated in controls (R2=0.15, p=0.021) but not in patients (R2=0.006, p=0.64), possibly indicating an osteoclastic disorder . Sclerostin levels in patients and controls were comparable (51.56±12.05 vs 50.98±13.55 pmol/L, p=0.84). Lower values were found in girls (49.1±12.7 vs 53.9±12.3 pmol/L, p=0.05) and in prepubertal children (47.3±11.6 vs 53.3±12.9 pmol/L, p=0.02). Sclerostin values significantly and gradually increased in children through pubertal Tanner stages 1 to 3, then reduced in stage 4 adolescents and increased again in pubertal stage 5 adolescents (ANOVA F=4.56, p=0.0024). Sclerostin levels were positively correlated with logCTX, logOsteocalcin and BMD Z-scores. Dickkopf-1 levels were found higher in patients(13.56±5.34 vs 11.35±3.76 pmol/L, p=0.0194), in boys (13.36±4.04 vs 11.72±5.14 pmol/L, p=0.02) and prebubertal children (13.61±4.87 vs 11.83±4.56 pmol/L, p=0.05). Dickkopf-1 was positively associated with logCTX, logOsteocalcin and IGF-1 in both groups, while in patients it was associated with OPG and fasting plasma glucose. The lowest dickkopf-1 values were found in Tanner stage 3 adolescents. Conclusions: RANKL/OPG axis seems to be significantly activated in patients with T1DM. These changes could indicate abnormal osteoclast function, while lower bone turnover could indicate abnormal osteoblast function and both could be associated with the lower bone mass, found in T1DM patients. Children and adolescents with T1DM had similar sclerostin but higher levels of dickkopf-1 than controls, indicating a downregulated Wnt/b-catenin bone metabolic pathway. Dickkopf-1 association with OPG and plasma fasting glucose in patients could indicate dickkopf-1 implication in RANKL/OPG axis dysregulation in that group. The decrease in sclerostin values observed in pubertal stage 4 adolescents and dickkopf-1 values in pubertal stage 3 adolescents coincide with the concurrent growth spurt, and are consistent with sclerostin and dickkopf-1 physiology as inhibiting signals. The only current realistic measures against bone disease in patients with T1DM are optimal glycaemic control along with regular physical exercise.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsentidis, Charalampos
  • Τσεντίδης, Χαράλαμπος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37677

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsentidis, Charalampos; Τσεντίδης, Χαράλαμπος. Μελέτη του μεταβολισμού των οστών σε παιδιά με σακχαρώδη διαβήτη τύπου Ι: ο ρόλος της σκληροστίνης. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/37677